In contrast to the utilization of autophagy inhibitors, when the mtKRAS CRC cell lines were treated with a dual inhibitor for AKT/mTOR, PI-103, the protein levels of PXR were significantly elevated (1.8- to 2.9-fold). This evidence concerns the gene AKT1 and colorectal carcinoma.